Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)
Clinical trial NCT01471379 · TERMINATED
Trial details
- NCT number
- NCT01471379
- Sponsor
- Spencer Dorn, MD, MPH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-02-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.